GC Therapeutics (Series A)

Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$146,758,644

Company Info
Founders
Parastoo Kohshakhlagh
Company Description
A biotech company using synthetic biology to program stem cells into any cell type, purportedly with best-in-class efficiency, speed, and scalability; they dictate cells fates in a single step and have validated cells for many applications. GC Therapeutics uses synthetic biology to efficiently, quickly, and scalablely program patient-derived stem cells into any cell type.
Market
Healthcare & Wellness
Coinvestors
Mubadala Capital,Cormorant,AH Bio Fund

Links